Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAI: Paracetamol and Ibuprofen/Indomethacin for PDA
NCT03648437Phase 1Terminated
- Sponsor
- University of Oulu
- Start
- Sep 2018
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of acetaminophen in patent ductus arteriosus (PDA) (4 arms), sponsored by University of Oulu. Primary endpoint: Ductal closure up to 12 weeks. Started Sep 2018; status: terminated.
02
Drugs
acetaminophen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on NCT03648437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03648437.